clopidogrel (Alvogen Inc)
Structured Review
![Representative platelet mapping TEG tracing result. TEG platelet mapping tracings from an individual in the <t>clopidogrel</t> group are provided, with results shown before and after drug administration. Each tracing was obtained using citrated TEG analysis. The TEG software calculates the contribution of ADP-induced platelet activation to maximal amplitude using the following formula: ([MA ADP – MA fibrin /MA thrombin – MA fibrin ] × 100) and subtracts this value from 100 to derive percentage platelet inhibition. TEG, thromboelastography; MA, maximum amplitude.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6556/pmc12176556/pmc12176556__fvets-12-1555641-g001.jpg)
Clopidogrel, supplied by Alvogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clopidogrel/product/Alvogen Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Evaluation of clopidogrel impact on canine platelet function using flow cytometry and thromboelastography platelet mapping"
Article Title: Evaluation of clopidogrel impact on canine platelet function using flow cytometry and thromboelastography platelet mapping
Journal: Frontiers in Veterinary Science
doi: 10.3389/fvets.2025.1555641
Figure Legend Snippet: Representative platelet mapping TEG tracing result. TEG platelet mapping tracings from an individual in the clopidogrel group are provided, with results shown before and after drug administration. Each tracing was obtained using citrated TEG analysis. The TEG software calculates the contribution of ADP-induced platelet activation to maximal amplitude using the following formula: ([MA ADP – MA fibrin /MA thrombin – MA fibrin ] × 100) and subtracts this value from 100 to derive percentage platelet inhibition. TEG, thromboelastography; MA, maximum amplitude.
Techniques Used: Software, Activation Assay, Inhibition
Figure Legend Snippet: The mean of the platelet mapping TEG parameter within groups over time. This figure shows the mean values of platelet mapping TEG parameters in the clopidogrel (solid line) and placebo (dashed line) groups on Days 0 and 7. Parameters measured include inhibition (%) and aggregation (%) to assess platelet inhibition and aggregation, respectively, along with MA values attributed to thrombin, fibrin, and ADP (MA_thrombin, MA_fibrin, and MA_ADP), which reflect platelet function in response to different activation pathways. * p < 0.05, indicating a significant difference between results for days 0 and 7 within each group. TEG, thromboelastography; MA, maximum amplitude; ADP, adenosine diphosphate.
Techniques Used: Inhibition, Activation Assay
Figure Legend Snippet: Results of the mean percentage of CD62P-positive cells and mean fluorescence intensity (MFI) in flow cytometry within groups over time. This figure shows the mean percentage of CD62P-positive cells in flow cytometry analysis for (A) the clopidogrel and (B) placebo groups on days 0 and 7. It also shows the results of the MFI in flow cytometry for (C) the clopidogrel group and (D) placebo group over time. Various conditions are shown, including unstimulated samples and samples stimulated with 20 μM ADP, 20 μM ADP + 20 μM epinephrine, 20 μM ADP + 12.5 μg/mL collagen, and 20 μM epinephrine. * p < 0.05 and ** p < 0.01, indicating a significant difference between results for days 0 and 7 within each group. ADP, adenosine diphosphate.
Techniques Used: Fluorescence, Flow Cytometry
Figure Legend Snippet: Individual results of platelet mapping TEG and flow cytometry in the clopidogrel group. This figure shows platelet mapping TEG and flow cytometry parameters for each dog in the clopidogrel group on days 0 and 7. Each line represents a different individual (identified by different colors and symbols). The parameters include MFI for ADP + epinephrine stimulation, aggregation (%), inhibition (%), and the percentage of CD62P-positive cells in flow cytometry. Despite baseline differences, all dogs exhibited a marked and consistent reduction in platelet function following clopidogrel treatment. ADP, adenosine diphosphate; MFI, mean fluorescence intensity; TEG, thromboelastography.
Techniques Used: Flow Cytometry, Inhibition, Fluorescence